Industry Leaders to Discuss the Transformative Shift from Recreational Cannabis to Pharmaceutical Applications LITTLETON, Colo. and CHICAGO , June 3, 2025 /PRNewswire/ -- DeFloria, Inc. , the botanical-drug developer advancing the first of its kind AJA001 oral solution for autism spectrum disorder (ASD), today announced it will be featured in a high-profile investor panel at the Benzinga Cannabis Capital Conference in... Read More